What is the ICD‑10 code for a 44‑year‑old Black male with mild leukopenia consistent with benign ethnic neutropenia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

ICD-10 Code for Benign Ethnic Neutropenia

The appropriate ICD-10 code for a 44-year-old Black male with mild leukopenia consistent with benign ethnic neutropenia is D70.4 (Cyclic neutropenia) or more appropriately D72.818 (Other decreased white blood cell count), though neither perfectly captures this specific benign condition.

Understanding Benign Ethnic Neutropenia

Benign ethnic neutropenia (BEN), also known as Duffy-null associated neutrophil count (DANC), is a common hematologic finding in individuals of African, Middle Eastern, and West Indian descent 1, 2. This condition affects approximately two-thirds of Black patients in the US and is characterized by:

  • Lower baseline absolute neutrophil counts (ANC): Reference range of 1210-5390 cells/μL compared to standard ranges 1
  • No increased infection risk: Patients are clinically well despite neutropenia 2, 3
  • Genetic basis: Associated with ACKR1/DARC gene mutation (rs2814778), specifically the Duffy-null red cell phenotype 1, 4

ICD-10 Coding Challenges

The ICD-10-CM system lacks a specific code for benign ethnic neutropenia, creating documentation challenges 5. Available options include:

Most Appropriate Codes:

  • D72.818 - Other decreased white blood cell count (most accurate for chronic benign neutropenia)
  • D70.4 - Cyclic neutropenia (less accurate but sometimes used)
  • D72.819 - Decreased white blood cell count, unspecified

Codes to AVOID:

  • D70.0-D70.3 - Agranulocytosis or severe neutropenia codes (inappropriate as BEN is not severe)
  • D70.9 - Neutropenia, unspecified (too nonspecific and implies pathology)

Clinical Implications for Coding

The critical issue is that using standard neutropenia codes may inappropriately trigger:

  1. Treatment modifications: Unnecessary dose reductions of chemotherapy or immunomodulatory drugs 1, 5
  2. Clinical trial exclusions: Patients may be inappropriately excluded from trials 6, 5
  3. Adverse event misclassification: BEN-related low counts incorrectly graded as treatment toxicity 5
  4. Healthcare disparities: Contributes to undertreatment of cancer in Black patients 1

Documentation Recommendations

When coding for this patient:

  • Use D72.818 with detailed clinical documentation stating "benign ethnic neutropenia" or "Duffy-null associated neutropenia"
  • Document baseline ANC values to establish this is chronic and stable
  • Note absence of infections or other cytopenias
  • Consider documenting Duffy antigen status if tested (Fy(a-b-) phenotype) 3, 4
  • Specify this is NOT pathologic neutropenia requiring intervention

Key Clinical Pitfalls

Avoid these common errors 1, 6:

  • Do not reduce doses of lenalidomide, pomalidomide, or other medications based solely on ANC in BEN patients
  • Do not exclude from CAR-T therapy eligibility due to baseline neutropenia
  • Do not initiate G-CSF or other interventions for stable, asymptomatic neutropenia
  • Consider genetic confirmation (ACKR1/DARC testing) when available to document BEN definitively 4

The lack of a specific ICD-10 code for this common condition represents a significant gap in the classification system that disproportionately affects minority populations 7, 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.